Try our Advanced Search for more refined results
March 12, 2012
ASTRAZENECA PHARMACEUTICALS LP v. FOOD AND DRUG ADMINISTRATION et al
Case Number:
1:12-cv-00388
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 26, 2012
AstraZeneca Can't Get FDA Tip-Off On Generic Approvals
AstraZeneca PLC on Monday unsuccessfully tried to force the U.S. Food and Drug Administration to notify it before approving a generic form of its antipsychotic drug Seroquel, two days after losing its bid to delay the approval of Seroquel generics with labels that omit hyperglycemia warnings.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login